Basics Zentalis Pharmaceuticals, Inc. IPO Date: April 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $100.43M Activated in VL: True Average Daily Range Avg Daily Range: $0.84 | 3.42% Avg Daily Range (30 D): $0.04 | 2.80% Avg Daily Range (90 D): $0.05 | 3.27% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .59M Avg Daily Volume (90 D): .65M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 188 Avg Trade Size (Sh.) (90 D): 185 Institutional Trades Total Inst.Trades: 1,917 Avg Inst. Trade: $2.1M Avg Inst. Trade (30 D): $.74M Avg Inst. Trade (90 D): $.69M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $.74M Avg Closing Trade (90 D): $.69M Avg Closing Volume: 121.31K     News Sep 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold Aug 7, 2025 @ 12:28 AM Zentalis (ZNTL) Q2 Loss Narrows 70% Source: Jesterai Jul 1, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold Jun 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Apr 1, 2025 @ 9:30 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.07 $-.37 $-.37 Diluted EPS $-2.07 $-.37 $-.37 Revenue $ 26.87M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -149.32M $ -26.69M $ -26.87M Operating Income / Loss $ -165.26M $ -33.73M $ -36.06M Cost of Revenue $ $ $ Net Cash Flow $ -2.25M $ 1.47M $ -4.33M PE Ratio